Propofol anesthesia or with surgery decreased the expression of BDNF and p-TrkB, but SAHA reversed the reduction. by Yunlin Feng (3043659)

“…SAHA alleviated the decrease of p-TrkB protein levels caused by propofol anesthesia or surgery significantly, though the levels of p-TrkB protein in Surgery+SAHA were still lower than Control+DMSO group. …”

Murine gastric pH decreases in additional models of intestinal damage. by Sarah E. Woodward (19429623)

Early IOP lowering response following injection with ssAAV2-STC-1-FLAG. by Gavin W. Roddy (7320446)

“…After an initial, non-significant decrease in IOP in both ssAAV2-STC-1-FLAG treated mice and ssAAV2-GFP control mice at day 1, and a return to baseline with ssAAV2-GFP by day 2, significant IOP lowering was seen following treatment with ssAAV2-STC-1-FLAG starting at day 2. …”

ACT and ISO decrease pathological changes in LPS-induced AKI mice. by Jing Lian (1671991)

HFD decreases intermediate-term memory. by Tong Yue (6033305)

“…<p>(A) The survival rate of 10d <i>Canton-S</i> fed with ND or HFD was observed for 7 days. …”

Ribosomal subunit pathways are decreased in <i>Resf1</i> knockdown cells. by Megan R. Majocha (18529925)

Intracellular retention, but not shedding of NKp65 molecules containing threonine at amino acid position 131 causes decreased surface expression. by Julian Leonard Lino Heller (22049674)

Decreased production of Reg3γ and β-defensins in IEC of OH mice. by Limin Liu (201430)

Subjects:

Discontinuous DEX PK raw data from repeated study. by Kavya Annu (11587215)

Subjects:

Kaplan-Meier curves for the effect of VD₃ sufficiency vs. deficiency on survival of mice from BCR-ABL Arf-/- leukemia. by Kavya Annu (11587215)

Subjects:

Plasma DEX concentrations in C57BL/6 VD₃ sufficient and deficient mice on a discontinuous DEX regimen. by Kavya Annu (11587215)

Subjects:

Serum 25(OH)VD3 levels in VD₃ sufficient and deficient mice. by Kavya Annu (11587215)

Subjects:

Cartoon depicting dexamethasone and dasatinib metabolism and efflux transport in intestine and liver. by Kavya Annu (11587215)

Subjects:

Differences in plasma and gut dexamethasone concentrations following the oral discontinuous DEX regimen leads to tissue specific activation of GCR and PXR. by Kavya Annu (11587215)

Subjects:

Gene expression (qPCR) data from livers of C57BL/6 mice before and after DEX treatment. by Kavya Annu (11587215)

Subjects:

Cyp and transporter gene expression in duodenum of VD₃ sufficient and deficient mice. by Kavya Annu (11587215)

Subjects:

Raw data from survival study in VD₃ sufficient vs. deficient male mice from BCR-ABL ALL when treated with dexamethasone. by Kavya Annu (11587215)

Subjects:

Dexamethasone plasma pharmacokinetics in male and female VD₃ sufficient and deficient mice, aged 14 weeks, after a single oral gavage of 2 mg/kg dexamethasone phosphate. by Kavya Annu (11587215)

Subjects:

Cyp and transporter gene expression in liver and kidney of 12-week-old hCYP3A4 mice. by Kavya Annu (11587215)

Subjects:

Induction of duodenal and hepatic Cyps in VD₃ deficient mice after DEX treatment. by Kavya Annu (11587215)

Subjects: